Furthermore, human autoantibodies directed against AQP4 from patients with neuromyelitis optica (NMO) impaired AQP4-M23 dynamic distribution and, consequently, astrocyte process and synaptic activity. This evidence concerns the gene AQP4 and neuromyelitis optica.